Ocugen, Inc. — Director's Dealing 2021

Jul 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-07-30

Reporting Person: Kompella Uday (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-30	Common Stock	M	10000	$1.83	Acquired	560674	Direct
2021-07-30	Common Stock	S	10000	$6.8072	Disposed	550674	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-30	Option (right to buy)	$1.83	M	10000	Disposed	2031-01-01	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	479416.0	Indirect

Footnotes

F1: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.76 to $6.85. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: The option, initially representing a right to purchase a total of 126,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates.